GPC

Which Is the Better Valuation Metric? The P/E Ratio or the PEG Ratio: Part 1

2016-10-28

Research Articles

Introduction Recently, I have been engaged in rather intense discussions regarding the validity of P/E ratios versus PEG ratios as proper or appropriate valuation metrics.  I generally find these types of debates befuddling for a couple of reasons.  One, they are often a result of a failure to communicate.  Either party or sometimes both parties […]

Premier Dividend Growth Stocks: Is There Any Value? A Sector By Sector Summary Review: Part 1

2016-08-22

Research Articles

Introduction As a value investor, I must admit to being very frustrated with the valuations I’m seeing on high-quality blue-chip dividend growth stocks.  I have been vigorously searching for fairly valued dividend growth stocks to invest in.  I have thoroughly screened and evaluated every company in the S&P Dividend Aristocrats, all three of the CCC […]

Many Of My Dividend Growth Stocks Have Become Overvalued, What Do I Do Now?

2013-04-25

Research Articles

Introduction To me, there’s almost nothing better than finding a great company that I truly want to own at a fair valuation, or better yet, undervalued.  In the long run, it has been my experience that this usually leads to outsized future returns, especially if you buy stocks when they are undervalued at the time.  […]

Blue-Chip Dividend Aristocrats – There is a Lot of Value in this Market: Part 4

2012-10-11

Research Articles

This is the fourth in a series of articles designed to counter a pervasive attitude that common stocks are expensive today.  Furthermore, we would agree with those that contend that we have been in a stealth bull market for the last 18 months or more.  However, would also contend that stocks were so cheap prior […]

Our Top 40 Favorite Dividend Champions: Blue-chip Dividend Growth Stocks Today’s Strong Option for Retirement Portfolios Part 2

2012-05-23

Research Articles

In part one of this two-part series (Found Here) I laid the groundwork for why I believe that blue-chip dividend paying US equities represent not only a viable, but also a safer investment choice than many give them credit for. I also pointed out why I believe the risk profile on bonds is currently upside […]

Gilead Sciences Inc: Strong Growth At An Unreasonably Low Price

2012-05-23

FAST Graphs At-A-Glance

Gilead Sciences Inc (GILD) is an innovative healthcare company with a strong record of historical earnings growth and expectations for above-average growth into the future.  Nevertheless, Mr. Market seems unwilling to recognize the past and future earnings power of this niche pharmaceutical growth stock.  Consequently, the company trades at a single digit PE ratio that […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.